B. Clark

Ectopic luteinizing hormone secretion and anovulation.

L. Nieman, P. Conn, G. Uwaifo, 2003, The New England journal of medicine.

Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins.

J. Teruya-Feldstein, M. Fleisher, R. Comenzo, 2006, Blood.

Diagnostic Sensitivity of Bronchoalveolar Lavage versus Lung Fine Needle Aspirate

A. Abati, C. Copeland, B. Clark, 2002, Modern Pathology.

Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-α 2a

A. Ropper, B. Clark, K. Gorson, 1998, Neurology.

Malignant melanoma of the prostate: a case report.

G. Wise, B. Clark, Jean Wong, 2008, The Canadian journal of urology.

Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a.

A. Ropper, B. Clark, K. Gorson, 1998, Neurology.

Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy

R. Riley, J. Ben-Ezra, B. Clark, 2009, Journal of clinical laboratory analysis.

Rectal leiomyosarcoma: an unusual rectal malignancy mimicking fecal impaction in a 19-year-old man.

K. Iswara, B. Clark, Ting-Hui Hsieh, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Clinicopathologic Features and Long-Term Outcomes of 293 Phyllodes Tumors of the Breast

D. Giri, A. Barrio, K. V. Van Zee, 2007, Annals of Surgical Oncology.

Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer.

F. Guadagni, J. Schlom, C. Van Waes, 2002, Cancer research.

Al Amyloidosis in a Patient with a T60a Ttr Mutation

J. Teruya-Feldstein, A. Solomon, C. Murphy, 2007 .

Possible role of Stat5a in rat mammary gland carcinogenesis

L. Shan, Minshu Yu, E. Snyderwine, 2004, Breast Cancer Research and Treatment.

Risk-Adapted Melphalan with Stem Cell Transplant (Sct) and Adjuvant Dexamethasone (Dex) +/- Thalidomide (Thal) Achieves Low Treatmentrelated Mortality and High Hematologic Response Rates

J. Teruya-Feldstein, M. Fleisher, M. Stubblefield, 2007 .